Omnigen BV is a biotechnology and IT company based in The Netherlands, with the slogan "We make the world healthier." Established in 2012, Omnigen utilizes biotechnology and computational biology to personalize healthcare and enhance quality of life. The company offers data analysis, custom software solutions, and consultancy services in bioinformatics.
In November 2015, Omnigen secured Pre Seed Round investment from ACE (Amsterdam Center for Entrepreneurship), demonstrating early support and validation from a prominent investor. This reflects confidence in the company's potential and contributes to its growth and development.
Omnigen's focus on leveraging biotechnology and computational biology for the betterment of society aligns with the increasing demand for personalized healthcare solutions. While a relatively young company, Omnigen's commitment to harnessing the power of science to enhance healthcare signifies a promising trajectory in the biotechnology and IT industries.
No recent news or press coverage available for Omnigen BV.